Population Carrier Frequency of HMSH2 and HMLH1 Mutations

Overview

Journal Br J Cancer

Specialty Oncology

Date 2000 Dec 6

PMID 11104559

Citations 23

Authors

M G Dunlop

S M Farrington

I Nicholl

L Aaltonen

G Petersen

M Porteous

A Carothers

Affiliations

Soon will be listed here.

Abstract

Knowledge of population carrier frequency for DNA mismatch repair (MMR) gene mutations would contribute to understanding the burden of cancer due to genetic susceptibility, but robust prevalence estimates are lacking. To estimate carrier frequency, we genotyped a cohort of relatives of mutation carriers and determined their colorectal cancer prevalence. Systematic Finnish and US data were combined with Scottish genotype and cancer prevalence data in a Bayesian calculation. The estimated carrier prevalence in the population aged 15-74 years is 1:3139 (95% Cl = 1:1247-1:7626) and these carriers are at high risk of colorectal and other cancers.

Citing Articles

An Overview of Autosomal Dominant Tumour Syndromes with Prominent Features in the Oral and Maxillofacial Region.

Kennedy R, Thavaraj S, Diaz-Cano S Head Neck Pathol. 2017; 11(3):364-376.

PMID: 28110467 PMC: 5550396. DOI: 10.1007/s12105-017-0778-1.

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.

Win A, Jenkins M, Dowty J, Antoniou A, Lee A, Giles G Cancer Epidemiol Biomarkers Prev. 2016; 26(3):404-412.

PMID: 27799157 PMC: 5336409. DOI: 10.1158/1055-9965.EPI-16-0693.

Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.

Chau R, Dashti S, Ait Ouakrim D, Buchanan D, Clendenning M, Rosty C Int J Epidemiol. 2016; 45(3):940-53.

PMID: 27063605 PMC: 5697347. DOI: 10.1093/ije/dyw036.

Hereditary cancer syndromes as model systems for chemopreventive agent development.

Walcott F, Patel J, Lubet R, Rodriguez L, Calzone K Semin Oncol. 2016; 43(1):134-145.

PMID: 26970132 PMC: 10433689. DOI: 10.1053/j.seminoncol.2015.09.015.

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Ait Ouakrim D, Dashti S, Chau R, Buchanan D, Clendenning M, Rosty C J Natl Cancer Inst. 2015; 107(9).

PMID: 26109217 PMC: 4651105. DOI: 10.1093/jnci/djv170.